SIC
XBI icon

Sterling Investment Counsel’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sterling Investment Counsel’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
1,599
+2
+0.1% +$270 0.06% 173
2026
Q1 		$204K Buy
+1,597
New +$199K 0.06% 189
2025
Q2 		– Sell
-2,862
Closed -$232K – 180
2025
Q1 		$232K Buy
+2,862
New +$256K 0.08% 157
2024
Q4 		– Sell
-4,221
Closed -$417K – 176
2024
Q3 		$417K Sell
4,221
-40
-0.9% -$3.93K 0.15% 99
2024
Q2 		$395K Buy
4,261
+273
+7% +$24.5K 0.16% 89
2024
Q1 		$378K Buy
3,988
+740
+23% +$68.7K 0.17% 94
2023
Q4 		$290K Sell
3,248
-54
-2% -$4.01K 0.15% 114
2023
Q3 		$241K Hold
3,302
– – 0.14% 128
2023
Q2 		$275K Sell
3,302
-1
-0% -$84 0.15% 116
2023
Q1 		$252K Buy
3,303
+54
+2% +$4.48K 0.15% 130
2022
Q4 		$270K Buy
3,249
+644
+25% +$52.1K 0.17% 127
2022
Q3 		$207K Sell
2,605
-300
-10% -$25.3K 0.15% 131
2022
Q2 		$216K Hold
2,905
– – 0.16% 133
2022
Q1 		$261K Buy
+2,905
New +$268K 0.18% 120

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Sterling Investment Counsel's XBI Position: Q2 2026 in Review

Sterling Investment Counsel increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.13% in Q2 2026, buying an estimated $270 and bringing the position to 1,599 shares worth $253K. The position accounts for 0.06% of the portfolio, ranked #173.

Sterling Investment Counsel first reported a position in XBI in Q1 2022 and has held it in 14 quarters since. The position peaked at $417K in Q3 2024. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Sterling Investment Counsel held 1,599 shares of State Street SPDR S&P Biotech ETF worth $253K as of Q2 2026.
  • Sterling Investment Counsel bought 2 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $270.
  • State Street SPDR S&P Biotech ETF made up 0.06% of Sterling Investment Counsel's portfolio in Q2 2026, its #173 holding.
  • Sterling Investment Counsel first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 14 quarters since.
  • Sterling Investment Counsel's State Street SPDR S&P Biotech ETF position peaked at $417K in Q3 2024.
  • 393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.